Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

PLXPLX
Showing 8 of 13 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in PROTALIX BIOTHERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 475,922 shares of PLX (PROTALIX BIOTHERAPEUTICS INC), worth $1.1M as of 2026-Q2. The position was increased (+89.3% shares). PLX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$1.1M

Current Shares

475,922

Total Value Change

+$1.1M

Total Shares Change

+425,681

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
475,922
+89.3%
$1.1M0.0%$2.33
40
2026-Q1
Decreased
251,345
-4.4%
$545,4180.0%$2.17
0
2025-Q4
Increased
262,809
+74.2%
$473,0560.0%$1.80
36
2025-Q3
Increased
150,829
+47.6%
$334,8410.0%$2.22
22
2025-Q2
Decreased
102,178
-64.7%
$151,2230.0%$1.48
0
2025-Q1
Increased
289,461
+482.3%
$741,0200.0%$2.56
40
2024-Q4
Decreased
49,710
-1.1%
$93,4550.0%$1.88
0
2024-Q3
Decreased
50,241
-89.1%
$51,2460.0%$1.02
0

Other major holders of PLX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used